Metta Clinical Research Private Limited
About Metta Clinical Research Private Limited
Data last updated:
Metta Clinical Research Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 11 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74999MH2018PTC309329. Its GSTIN is 27AALCM8348M1ZN (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹20,000. It is led by directors Sapana Jayesh Dhawale and Jayesh Shrihari Dhawale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 3232 Plot No 42 Vasant Nagar, Nagpur, Maharashtra, India – 440027.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.28 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹2.64 Lakh (net margin 7.9%) and EBITDA of ₹3.34 Lakh (EBITDA margin 10%). Revenue has declined at a compounded annual rate (CAGR) of 32% over three years and 6% over five years.
Company details
Contact details
Metta Clinical Research Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No 3232 Plot No 42 Vasant Nagar, Nagpur, Maharashtra, India – 440027
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Metta Clinical Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Metta Clinical Research is professional, scientific and technical activities. In detail, this covers architectural and engineering activities; technical testing and analysis.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 71 | Architectural and engineering activities; technical testing and analysis |
To see the full business activity and turnover split of Metta Clinical Research Private Limited, buy the company report.
Financials of Metta Clinical Research Private Limited
FY 2025 filings availableMetta Clinical Research Private Limited reported revenue of ₹33.28 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 12% fall in the latest year. EBITDA rose 169% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | ||||
| Net Profit Margin | 7.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Metta Clinical Research Private Limited, buy the company report.
Board of directors of Metta Clinical Research Private Limited
Metta Clinical Research has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sapana Jayesh Dhawale | Director | 11 May 2018 | 8 Years 5 Months | Current |
| Jayesh Shrihari Dhawale | Director | 11 May 2018 | 8 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Metta Clinical Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Metta Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Metta Clinical Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCM8348M1ZN | Maharashtra | Active | 06 Sep 2018 |
To see the full GST registrations and return filing status of Metta Clinical Research Private Limited, buy the company report.
Recent activity
Metta Clinical Research Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Jayesh Shrihari Dhawale was appointed as Director on 11 May 2018.
Frequently asked questions
Metta Clinical Research is an active private limited company based in Nagpur, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 11 May 2018 (8+ years old) and is registered under CIN U74999MH2018PTC309329.
Metta Clinical Research has 2 current directors:
- Sapana Jayesh Dhawale - Director
- Jayesh Shrihari Dhawale - Director
The latest financial statements of Metta Clinical Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Metta Clinical Research is 27AALCM8348M1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Metta Clinical Research is U74999MH2018PTC309329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metta Clinical Research was incorporated on 11 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Nagpur.
Jayesh Shrihari Dhawale was appointed as Director on 11 May 2018. Sapana Jayesh Dhawale was appointed as Director on 11 May 2018.
The registered office of Metta Clinical Research is at House No 3232 Plot No 42 Vasant Nagar, Nagpur, Maharashtra, India – 440027.
Metta Clinical Research operates in the business services industry, in the miscellaneous business activities segment.
Metta Clinical Research can be reached at its registered office: House No 3232 Plot No 42 Vasant Nagar, Nagpur, Maharashtra, India – 440027.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
